Company Filing History:
Years Active: 2020-2025
Title: Elaine Greer: Innovator in Pharmaceutical Developments
Introduction
Elaine Greer, based in Groton, CT, is a prominent inventor in the field of pharmaceuticals, boasting a remarkable total of 11 patents. Her innovative contributions continue to advance medical science, particularly in the area of cancer treatment.
Latest Patents
Among her most recent patents is the discovery of solid-state forms of (S)-2-(((S)-6,8-difluoro-1,2,3,4-tetrahydronaphthalen-2-yl)amino)-N-(1-(2-methyl-1-(neopentylamino)propan-2-yl)-1H-imidazol-4-yl)pentanamide. This patent details several key aspects, including:
a) Solid-state forms of hydrobromide salts of the compound;
b) Pharmaceutical compositions that incorporate one or more solid-state forms of these hydrobromide salts, possibly alongside a pharmaceutically acceptable carrier;
c) Methods for treating tumors or cancers through the administration of these solid-state forms to subjects requiring treatment;
d) Procedures for preparing these solid-state forms effectively.
Career Highlights
Elaine is an essential member of Pfizer Corporation, where her work is integral to the development of innovative pharmaceutical solutions. Her dedication to research and development emphasizes her commitment to enhancing treatment options available in the market.
Collaborations
Throughout her career, Elaine has collaborated with esteemed colleagues like Stephen Anderson and Mark Maloney, further driving innovation in the pharmaceutical domain. These collaborations highlight the importance of teamwork in achieving groundbreaking advancements.
Conclusion
With a portfolio that includes 11 patents and innovative approaches to treating serious medical conditions, Elaine Greer exemplifies the spirit of invention. Her work is making a significant impact in the pharmaceutical industry, particularly in the quest for effective cancer therapies.